Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Gallelli

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
Drug Design, Development and Therapy|October 22, 2019
Escin: a review of its anti-edematous, anti-inflammatory, and venotonic propertiesLuca Gallelli
Infection Control and Hospital Epidemiology|April 21, 2020
Could COVID-19 represent a negative prognostic factor in patients with stroke?Antonio Siniscalchi, Luca Gallelli
American Journal of Respiratory and Critical Care Medicine|March 4, 2017
Direct Detection of Circulating MicroRNAs Unveiled the Absence of MicroRNA-218-5p in Smoker SubjectsErika Cione, Luca Gallelli
Annali Di Stomatologia|August 14, 2012
Pain management for dentists: the role of ibuprofenAlessandro Pozzi, Luca Gallelli
The Journal of Headache and Pain|January 30, 2017
O053. Interictal cerebral posterior circulation in migraineurs with aura: a trancranial color-coded duplexsonography pilot studyAntonio Siniscalchi, Luca Gallelli, Rosario Iannacchero
Multidisciplinary Respiratory Medicine|February 21, 2015
Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrroniumGirolamo Pelaia, Rosario Maselli, Luca Gallelli
Current Clinical Pharmacology|August 12, 2008
Drugs treatment of pain in multiple sclerosisAntonio Siniscalchi, Luca Gallelli, Giovambattista De Sarro
Clinical Drug Investigation|January 5, 2013
Effects of topiramate on dysaesthetic pain in a patient with multiple sclerosisAntonio Siniscalchi, Luca Gallelli, Giovambattista De Sarro
Parkinsonism & Related Disorders|August 15, 2006
Combined topiramate and declorazepam therapy in a patient affected by essential tremorAntonio Siniscalchi, Luca Gallelli, Giovambattista De Sarro
Current Drug Safety|April 7, 2016
Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?Piero Vasapollo, Erika Cione, Filippo Luciani, et al.
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
Drug Design, Development and Therapy|October 22, 2019
Escin: a review of its anti-edematous, anti-inflammatory, and venotonic propertiesLuca Gallelli
Infection Control and Hospital Epidemiology|April 21, 2020
Could COVID-19 represent a negative prognostic factor in patients with stroke?Antonio Siniscalchi, Luca Gallelli
American Journal of Respiratory and Critical Care Medicine|March 4, 2017
Direct Detection of Circulating MicroRNAs Unveiled the Absence of MicroRNA-218-5p in Smoker SubjectsErika Cione, Luca Gallelli
Annali Di Stomatologia|August 14, 2012
Pain management for dentists: the role of ibuprofenAlessandro Pozzi, Luca Gallelli
The Journal of Headache and Pain|January 30, 2017
O053. Interictal cerebral posterior circulation in migraineurs with aura: a trancranial color-coded duplexsonography pilot studyAntonio Siniscalchi, Luca Gallelli, Rosario Iannacchero
Multidisciplinary Respiratory Medicine|February 21, 2015
Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrroniumGirolamo Pelaia, Rosario Maselli, Luca Gallelli
Current Clinical Pharmacology|August 12, 2008
Drugs treatment of pain in multiple sclerosisAntonio Siniscalchi, Luca Gallelli, Giovambattista De Sarro
Clinical Drug Investigation|January 5, 2013
Effects of topiramate on dysaesthetic pain in a patient with multiple sclerosisAntonio Siniscalchi, Luca Gallelli, Giovambattista De Sarro
Parkinsonism & Related Disorders|August 15, 2006
Combined topiramate and declorazepam therapy in a patient affected by essential tremorAntonio Siniscalchi, Luca Gallelli, Giovambattista De Sarro
Current Drug Safety|April 7, 2016
Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?Piero Vasapollo, Erika Cione, Filippo Luciani, et al.
Pageof 28